RajSPruthiMDMHA, FACS

Urology • San Francisco, CA

Minimally Invasive Surgery, Surgical Oncology

Professor and Chair of the University of California, San Francisco, Department of Urology

Join to view full profile

Dr. Pruthi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pruthi's full profile

Already have an account?

Office
550 16th Street, 6th floor
Box #1695
San Francisco, CA 94143
Phone+1 415-353-7098

Summary

Dr. Raj Pruthi is a urologist in San Francisco, CA and is Professor and Chair at the University of California, San Francisco. He received his medical degree from Duke University School of Medicine and has been in practice 25 years. He specializes in urologic oncology and is experienced in prostate cancer, bladder cancer, minimally invasive surgery, and urologic oncology.

Education & Training

University of North CarolinaMHA, Masters of Health Administration , 2015 - 2017
Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 1992 - 1998
Duke University School of MedicineClass of 1992
Stanford UniversityBA, BS, Economics (BA), Biology (BS), 1984 - 1988

Certifications & Licensure

FL State Medical License 2023 - 2025
CA State Medical License 2019 - 2023
NC State Medical License 1998 - 2020
LA State Medical License 1999 - 2000
American Board of Urology Urology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2011-2014
America's Top Doctors for Cancer Castle Connolly, 2010-2013
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy Start of enrollment: 2003 Apr 01
Terminated
Phase 2
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer Start of enrollment: 2006 May 01
Completed
Phase 2
A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy Start of enrollment: 2009 Mar 01
Completed
Phase 4
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
Completed
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Terminated
Join now to see all

Publications & Presentations

PubMed

38 citations
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.
Jonathan Chou, Kai Trepka, Martin Sjöström, Emily A Egusa, Carissa E Chu
European Urology Oncology. 2022-12-01
439 citations
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Dipen J. Parekh, Isildinha M. Reis, Erik P. Castle, Mark L. Gonzalgo, Michael Woods
Lancet. 2018-06-23
385 citations
Prospective Randomized Controlled Trial of Robotic versus Open Radical Cystectomy for Bladder Cancer: Perioperative and Pathologic Results
Jeffrey W. Nix, Angela M Smith, Raj Kurpad, Matthew E. Nielsen, Eric Wallen
European Urology. 2010-02-01

Press Mentions

Perfect! OUWB Maintains 100% Success Rate in Urology with 2023 Early MatchFebruary 3rd, 2023
Health Tips This Experimental Prostate Cancer Treatment Is Shrinking TumorsApril 28th, 2017
New Guidelines on Bladder Cancer ManagementMay 14th, 2016

Professional Memberships

American College of Surgeons - ACS
Member